Cord blood infusion trial aims to beat long COVID fatigue
Symptom relief
Not yet recruiting
This phase 3 trial tests whether a single infusion of human umbilical cord blood, called REGENECYTE, can reduce fatigue in people with Long COVID. Sixty adults with post-COVID condition will receive either the cord blood or a placebo (salt water) and be monitored for changes in f…
Phase: PHASE3 • Sponsor: StemCyte, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC